In the mechanism of EZH2-mediated activation of Wnt/β-catenin signal to promote carcinogenesis, EZH2 acts as a transcription repressor, inhibiting Wnt antagonists by reducing the acetylation of H3K27, thereby promoting the development of different types of cancers [31, 32]. The gene discussed is EZH2; the disease is cancer.